Patricia Valerio, PhD,  —

Patricia holds a PhD in Neurobiology from the University of Basel, Switzerland, where she studied how hearing develops and functions. She is originally from Portugal and earned an MSc in Cellular and Molecular Biology, focusing on metabolic diseases, such as diabetes, and a BSc in Biomedical Pharmacy from the University of Coimbra. Patricia enjoys communicating science to inspire, educate and help different audiences understand its complexity and relevance.

Articles by Patricia Valerio

November 10, 2022 News by Patricia Valerio, PhD

Inhaled APN01, Potential PAH Therapy, Safe in Healthy Adults

An inhaled form of APN01 (alunacedase alfa), APEIRON Respiratory Therapies (AResT)’s investigational therapy for certain lung diseases, was safe and well-tolerated in healthy people, according to data from a Phase 1 clinical trial. “In addition to meeting all primary [goals] regarding the safety and tolerability of APN01 via a new…

November 9, 2022 News by Patricia Valerio, PhD

Virginia Venture Partners Invests in OxiWear Device for PH

Virginia Venture Partners — Virginia Innovation Partnership Corporation (VIPC)’s equity investment program — is investing in OxiWear and its modern ear-wearable device that’s designed to continuously monitor blood oxygen levels in people with pulmonary hypertension (PH). The OxiWear device alerts the user through a phone app when there’s…

Recent Posts


A Conversation With Rare Disease Advocates